NiebauerJBorjessonMCarreF, et al.
Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019;
26: 1549–1555.
2.
HalleMBinzenhöferLMahrholdtH, et al. Myocarditis in athletes: A clinical perspective. Eur J Prev Cardiol. Epub ahead of print 3 March 2020. DOI: 10.1177/2047487320909670.
3.
LechnerKvon SchackyCMcKenzieAL, et al.
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol2020;
27: 394–406.
4.
GroenhofTKJvan RijnBBFranxA, et al.
Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when. Eur J Prev Cardiol2017;
24: 1735–1745.
5.
AuneDSchlesingerSNoratT, et al.
Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol2018;
25: 1437–1451.
6.
AuneDSchlesingerSNoratT, et al.
Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol2019;
26: 279–288.
7.
SkotsimaraGAntonopoulosASOikonomouE, et al.
Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis. Eur J Prev Cardiol2019;
26: 1219–1228.
CavarrettaEMaffessantiFSperandiiF, et al.
Reference values of left heart echocardiographic dimensions and mass in male peri-pubertal athletes. Eur J Prev Cardiol2018;
25: 1204–1215.
10.
Giorgi-PierfranceschiMArtomNDi PasqualeG, et al.
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation. Eur J Prev Cardiol2019;
26: 660–663.
11.
LopesRDAlexanderJHAl-KhatibSM, et al.;
ARISTOTLE Investigators. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: Design and rationale. Am Heart J2010;
159: 331–339.
